CD8A and myeloid sarcoma: Notably, a higher frequency of CD8+ effector memory T cells was detected in the CSF of AD patients with dementia compared to controls, suggesting CD8+ T cells contribute to brain damage in both AD and MS with similar underlying mechanisms (117, 121).